Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (2112)	5/18/2004 4:34:42 PM
From: Icebrg	Read Replies (1) of 3044

Millennium Pharmaceuticals "market perform" Tuesday, May 18, 2004 2:31:27 PM ET JMP Securities NEW YORK, May 18 (New Ratings) - Analysts at JMP Securities maintain their "market perform" rating on Millennium Pharmaceuticals Inc (MLNM.NAS). In a research note published this morning, the analysts mention that Millennium Pharmaceuticals reported positive results from the Phase III APEX study of Velcade, the company's drug for the treatment of relapsed multiple myeloma (MM). The positive results would enable the company to expand its customer base, the analysts believe. However, JMP Securities believes that further catalysts are required to boost the company's share price in the near future.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next